| Literature DB >> 21062811 |
Erik B Pedersen1, Jakob T Nielsen, Claus Nielsen, Vyacheslav V Filichev.
Abstract
Two G-quadruplex forming sequences, 5'-TGGGAG and the 17-mer sequence T30177, which exhibit anti-HIV-1 activity on cell lines, were modified using either locked nucleic acids (LNA) or via insertions of (R)-1-O-(pyren-1-ylmethyl)glycerol (intercalating nucleic acid, INA) or (R)-1-O-[4-(1-pyrenylethynyl)phenylmethyl]glycerol (twisted intercalating nucleic acid, TINA). Incorporation of LNA or INA/TINA monomers provide as much as 8-fold improvement of anti-HIV-1 activity. We demonstrate for the first time a detailed analysis of the effect the incorporation of INA/TINA monomers in quadruplex forming oligonucleotides (QFOs) and the effect of LNA monomers in the context of biologically active QFOs. In addition, recent literature reports and our own studies on the gel retardation of the phosphodiester analogue of T30177 led to the conclusion that this sequence forms a parallel, dimeric G-quadruplex. Introduction of the 5'-phosphate inhibits dimerisation of this G-quadruplex as a result of negative charge-charge repulsion. Contrary to that, we found that attachment of the 5'-O-DMT-group produced a more active 17-mer sequence that showed signs of aggregation-forming multimeric G-quadruplex species in solution. Many of the antiviral QFOs in the present study formed more thermally stable G-quadruplexes and also high-order G-quadruplex structures which might be responsible for the increased antiviral activity observed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21062811 PMCID: PMC3064782 DOI: 10.1093/nar/gkq1133
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.(A) The G-quartet, represented by four guanine residues. Hydrogen bonds are in dashed lines. (B) Structure of LNA with torsion angles labelled, INA and TINA monomers. (C) Parallel tetramolecular G-quadruplex (5′- TGGGAG). The formation of G-quartets is indicated by dashed lines. (D) Anti-parallel G-quadruplex structure of T30177 having anti-parallel folding topology proposed by Jing N.J. and Hogan M.E. (20).
Oligonucleotides synthesized and their anti-HIV inhibition efficiency at 1.0 µM
| Name | Sequence | DMT on (%) | DMT off (%) |
|---|---|---|---|
| ON1 | 5′- TGG GAG | 10 ± 3 | – |
| ON2 | 5′- TG | 65 ± 5 | – |
| ON3 | 5′- TG | 84 ± 8 | – |
| ON4 | 5′- | – | 0 |
| ON5 | 5′- T | 2 | – |
| ON6 | 5′- T | 75 ± 6 | – |
| ON7 | 5′- GTG GTG GGT GGG TGG GT | 28 ± 2 | 10 |
| ON7p | 5′- | – | – |
| ON8 | 5′- GTG | 84 ± 9 | 25 |
| ON9 | 5′- GT | 16 | 19 |
| ON10 | 5′- GTG GT | 77 ± 7 | 25 |
| ON11 | 5′- GTG GT | 76 ± 9 | 5 |
| ON12 | 5′- GTG GTG GGT GGG T | 61 ± 7 | 18 |
| ON13 | 5′- GTG GTG G | 72 ± 10 | 3 |
| ON14 | 5′- GTG GTG GGT GG | 75 ± 2% | 15 |
| ON15 | 5′- GTG GTG GGT | 100 ± 8 | 4 |
| ON16 | 5′- | – | 90 ± 6 |
| ON17 | 5′- | – | 89 ± 12 |
| ON18 | 5′- GTG GT | 0 | – |
| ON19 | 5′- GTG | 0 | – |
| ON20 | 5′- GTG | 0 | – |
| ON21 | 5′- | 0 | – |
| ON22 | 5′- | 16 | – |
| ON23 | 5′- | 63 ± 4 | – |
| ON24 | 5′- | 0 | – |
| ON25 | 5′- GTG GT | 87 ± 8 | - |
| ON26 | 5′- GTG GT | 78 ± 8 | - |
aP represents INA monomer, X represents TINA monomer, and represents LNA corresponding monomers, p represents phosphate group.
bThe test was not performed.
cNo effect was observed at 0.1 µM.
Figure 2.Nondenaturing 20% polyacrylamide gel, RPMI 1640 buffer (also used for the running buffer) run at 37°C. 5′-O-DMT-on compounds are marked as +, DMT-off as −. DNA ladder is composed of oligothymidylates of different length as indicated on the picture.
Figure 3.CD spectra of compounds ON1–ON6, all possess 5′-O-DMT group except ON4.
Figure 5.(A–C) Nondenaturing 20% polyacrylamide gel, RPMI 1640 buffer (also used for the running buffer) run at 37°C. 5′-O-DMT-on compounds are marked as +, DMT-off as −. DNA ladder is composed of oligothymidylates of different length as indicated on each picture. (D) Non-denaturing 20% polyacrylamide gel, 1 × TBE supplemented with 10 mM KCl (also used for the running buffer) run for 4.5 h at 10W at 37°C.
Figure 4.CD spectra of compounds ON7–ON10, ON18 and ON26, all possess 5′-O-DMT group.